Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
In Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. No. 2022-1889, __ F.4th ____ (Fed. Cir. Nov. 6, 2023), the case addresses whether a district court needs to consider the extrinsic evidence when the intrinsic record does not sufficiently render the term non-ambiguous. This is an appeal of the district court's claim construction order.
Find out more about Lexology or get in touch by visiting our About page. Register To view this article you need a PDF viewer such as Adobe Reader. If you can't read this PDF, you can view its text here. Go back to the PDF .
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
